Immunovant

5 followers

‌

Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated... Read more

Industries

Headquarters

New York, United States

Employees

Links

Org chart

Chief Executive Officer

Peter Salzmann

Collapse

Chief Financial Officer

Chief Medical Officer

Julia G. Butchko

Chief Development Officer

Chief Technology Officer

VP, Global Regulatory Affairs

VP, Marketing

VP, Quality

VP, Clinical Development

Rebecca Merlina

Svp, Global Head Of Quality

Christine Peña Blodgett

Vice President, Human Resources

Senior Director Of Marketing

Michael Geffner M.d.

Chief Medical Officer

Teams

Clinical Operations Team

20 members

Vice Presidents

10 members

Leadership Team

8 members

Similar companies

Halozyme Therapeutics

5 followers

REVOLUTION Medicines

5 followers

Kymera Therapeutics

5 followers

C4 Therapeutics

4 followers

Stemline Therapeutics

3 followers

Inari

3 followers

Prelude Therapeutics

3 followers

Active Motif

3 followers

Pivot Bio

2 followers

Vor Biopharma

2 followers

Generation Bio

2 followers

Explore companies